HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations.

Abstract
The molecular basis of the enzymatic defect responsible for delta-aminolevulinate dehydratase (ALAD) porphyria (ADP) was investigated in a 14-year-old male who presented clinical and laboratory findings typical of ADP. Nucleotide sequence analysis of ALAD cDNAs from the proband revealed two novel mutations, a 265G to A base transition (C1) and a 394C to T base transition (C2), resulting in amino acid substitutions, Glu89Lys and Cys132Arg, respectively. Both mutations were present within exon 5 of the ALAD gene, and appeared to influence the binding of zinc to the enzyme which is essential for enzyme activity. It was found that the C1 mutation was inherited from his father, while the C2 mutation was from his mother. Expression of these mutant ALAD cDNAs in Chinese hamster ovary cells produced normal ALAD mRNA levels, but markedly decreased ALAD protein and enzyme activity. These results suggest that the combination of the two aberrant ALADs with little enzyme activity accounts for the markedly decreased ALAD activity observed in the proband. This case represents the molecular analysis of the ALAD gene defects in the first case of ADP identified in North America, who is a compound heterozygote for two novel ALAD gene defects.
AuthorsReiko Akagi, Noriko Kato, Rikako Inoue, Karl E Anderson, Eileen K Jaffe, Shigeru Sassa
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 87 Issue 4 Pg. 329-36 (Apr 2006) ISSN: 1096-7192 [Print] United States
PMID16343966 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Lead
  • Porphobilinogen Synthase
  • Zinc
Topics
  • Adolescent
  • Animals
  • CHO Cells
  • Catalytic Domain
  • Cricetinae
  • Cricetulus
  • Erythrocytes (drug effects, enzymology)
  • Humans
  • In Vitro Techniques
  • Lead (pharmacology)
  • Male
  • Mitochondria (enzymology)
  • Mutation
  • Pedigree
  • Porphobilinogen Synthase (chemistry, genetics)
  • Porphyrias (enzymology, genetics)
  • Sequence Analysis, DNA
  • Zinc (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: